188 filings
DEFA14A
EOLS
Evolus Inc
26 Apr 24
Additional proxy soliciting materials
4:56pm
DEF 14A
EOLS
Evolus Inc
Definitive proxy
26 Apr 24
4:55pm
ARS
2023 FY
EOLS
Evolus Inc
26 Apr 24
Annual report to shareholders
4:55pm
8-K
EOLS
Evolus Inc
3 Apr 24
Departure of Directors or Certain Officers
4:29pm
8-K
EOLS
Evolus Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:59pm
424B5
g5fkag 8mt54ng49
11 Mar 24
Prospectus supplement for primary offering
9:00am
S-8
uhr3pt2vtmj2v
7 Mar 24
Registration of securities for employees
4:58pm
8-K
0eltvo
7 Mar 24
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
4:09pm
8-K
w0hv67 nvst3f3amwci
16 Jan 24
Evolus Announces Preliminary Unaudited Fourth Quarter
5:28pm
8-K
qoosz
20 Dec 23
Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe
8:33am
8-K
r1a4pojugx82uyzckejy
7 Nov 23
Evolus Reports Record Third Quarter 2023 Financial Results
4:24pm
S-8
aoq32vczn9 rjmyv8hx
6 Oct 23
Registration of securities for employees
5:27pm
8-K
vyj6yb3cx6iyslbnsd7p
2 Aug 23
Evolus Reports Second Quarter 2023 Results
4:08pm
8-K
6gr6zpab757xe
27 Jul 23
Results of Operations and Financial Condition
8:55am
8-K
uw9si63jlvp28rpx6
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:39pm
424B5
z6jmce2 uslgr5p5
9 Jun 23
Prospectus supplement for primary offering
4:30pm
EFFECT
auqv29ugjt
9 Jun 23
Notice of effectiveness
12:15am